Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen) [3]

Annals of Oncology

Volumn 10, Issue 11, 1999, Pages 1394-1395

  Locatelli, M ^a   Colleoni, M ^a   Noberasco, C ^a   Nole, F ^a   Orlando, L ^a   Munzone, E ^a   Peruzzotti, G ^a   Goldhirsch, A ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ALKALINE PHOSPHATASE BLOOD LEVEL; DOSE CALCULATION; DRUG INDUCED DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LIVER FUNCTION TEST; LIVER TOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032763525     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008356726147     Document Type: Letter

References (5)

1. Rizzi V. Cioschi B. Cartei G. Liver function tests and lidocaine metabolism (MEGX test) during 1 v. CM F therapy in breast cancer Anticancer Drugs 7 1996 846 850
2. Larroquette C.A. Hortobagyi G.N. Buzdar A.U. Holmes F.A. Subclinical hepatic toxicity during combination chemotherapy for breast cancer JAMA 256 1986 2988 2990
3. Vaughan W.P. Wilcox P.M. Alderson P.O. Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breast Med Pediatr Oncol 7 1979 351 359
4. Hirvikoski P.P. Kumpulainen E.J. Johansson R.T. Hepatic toxicity caused by adjuvant CMF/CNF in breast cancer patients and reversal by tamoxifen Breast Cancer Res Treat 44 1997 267 269
5. Hersh E.M. Wang U.G. Henderson E S Freireich E.J. Hepatotoxicity effects of methotrexate Cancer 19 1966 600 606